Cerebras IPO faces further delays

Despite delays, Cerebras remains confident in securing approval and plans to move forward with its IPO once the national security review is resolved.

Logo, Dynamite, Weapon

Cerebras Systems’ plans for a public listing remain in limbo as a national security review by the US government continues to delay the AI chipmaker’s IPO.

The review, conducted by the Committee on Foreign Investment in the United States (CFIUS), is assessing a $335 million investment from Abu Dhabi-based AI firm G42, which has faced scrutiny over its past ties to China.

While executives had hoped for a smoother process under President Trump, delays in filling key political positions have further complicated approval.

Without clarity on G42’s stake, investors remain cautious, making it difficult for Cerebras to move forward. The situation reflects a broader reality for Wall Street, as expectations of a more deal-friendly environment under Trump have yet to materialise.

Analysts suggest that instead of rolling back Biden-era policies, the administration is likely to maintain or even expand scrutiny on foreign investments, particularly those linked to China.

Instead of a setback, Cerebras remains optimistic that the deal will be approved, with plans to proceed with its IPO once clearance is granted.

The company, valued at $8 billion last year, has seen its worth nearly double since then. Meanwhile, G42 has distanced itself from Huawei and secured a national security agreement with the US in an effort to gain regulatory approval.

For more information on these topics, visit diplomacy.edu.